Skip to content
10-Q

Quarterly Report

STEADYMED LTD.

0001104659-17-051214

← back to feed
Filed
Aug 11, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2017 · Aug 11, 2017 26.56M sh
Cash And Equivalents Q2 2017 · Jun 30, 2017 $43.54M
Cash And Equivalents Q2 2017 · Dec 31, 2016 $23.22M
Cash And Equivalents Q2 2017 · Jun 30, 2016 $17.25M
Cash And Equivalents Q2 2017 · Dec 31, 2015 $31.85M
Stockholders Equity Q2 2017 · Jun 30, 2017 $19.8M
Stockholders Equity Q2 2017 · Dec 31, 2016 $14.31M
Current Liabilities Q2 2017 · Jun 30, 2017 $4.34M
Current Liabilities Q2 2017 · Dec 31, 2016 $6.36M
Current Assets Q2 2017 · Jun 30, 2017 $43.76M
Current Assets Q2 2017 · Dec 31, 2016 $23.38M
Total Assets Q2 2017 · Jun 30, 2017 $48.98M
Total Assets Q2 2017 · Dec 31, 2016 $28.16M
Net Income Q2 2017 · Jun 30, 2017 −$8.15M
Net Income Q2 2017 · Jun 30, 2017 −$26.71M
Net Income Q2 2017 · Jun 30, 2016 −$7.16M
Net Income Q2 2017 · Jun 30, 2016 −$13.43M
Capex Q2 2017 · Jun 30, 2016 $768K
Operating Cash Flow Q2 2017 · Jun 30, 2016 −$13.85M
Sga Expense Q2 2017 · Jun 30, 2016 $1.25M
Sga Expense Q2 2017 · Jun 30, 2016 $2.68M
Rd Expense Q2 2017 · Jun 30, 2016 $5.3M
Rd Expense Q2 2017 · Jun 30, 2016 $10.27M
Operating Income Q2 2017 · Jun 30, 2016 −$7.07M
Operating Income Q2 2017 · Jun 30, 2016 −$13.3M
Revenue Q2 2017 · Jun 30, 2016 $94K
Revenue Q2 2017 · Jun 30, 2016 $469K